Aethlon Medical
AEMD
22 hedge funds and large institutions have $1.85M invested in Aethlon Medical in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
8% less funds holding
Funds holding: 24 → 22 (-2)
35% less capital invested
Capital invested by funds: $2.83M → $1.85M (-$987K)
41% less call options, than puts
Call options by funds: $10K | Put options by funds: $17K
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$41.8K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$29.8K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.97K |
| 4 |
NF
NTB Financial
Centennial,
Colorado
|
+$2.39K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.19K |
Top Sellers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$149K |
| 2 |
Two Sigma Advisers
New York
|
-$79K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$74K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$66K |
| 5 |
Two Sigma Investments
New York
|
-$65.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Citadel Advisors
Miami,
Florida
| – | -$66K | -45 | Closed |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$5K | -3 | Closed |
|
AEMD Hedge Fund Activity: Q1 2022 in Review
22 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2022, worth a combined $1.85M — down 35% from $2.83M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of AEMD and 1 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $41.8K. The largest seller was Dimensional Fund Advisors, cutting an estimated $149K.
- 22 institutional investors held Aethlon Medical (AEMD) as of Q1 2022, down from 24 in Q4 2021.
- Funds reported $1.85M of Aethlon Medical stock for Q1 2022, down 35% quarter-over-quarter.
- 1 fund opened new Aethlon Medical positions in Q1 2022 and 3 closed out, a net change of -2 holders.
- The largest Aethlon Medical buyer in Q1 2022 was Renaissance Technologies, an estimated $41.8K added.
- The largest Aethlon Medical seller in Q1 2022 was Dimensional Fund Advisors, an estimated $149K sold.
Based on aggregated 13F filings for Q1 2022.